Form D — Linnaeus Therapeutics, Inc.
0001752026-26-000007 · filed 2026-04-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $10,000,000
- Total sold
- $4,992,000
- Minimum investment
- $1
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Linnaeus Therapeutics, Inc.
- CIK
- 1752026
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 30 WASHINGTON AVENUE, SUITE F
HADDONFIELD, NJ 08033 - Phone
- 856-433-1500
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Patrick Mooney · Executive OfficerHaddonfield, NJ Find on LinkedIn ↗
-
James Demetriades · DirectorHaddonfield, NJ Find on LinkedIn ↗
-
Michael Poisel · DirectorHaddonfield, NJ Find on LinkedIn ↗
-
Chris Arendt · DirectorHaddonfield, NJ Find on LinkedIn ↗
-
Todd Thomson · DirectorHaddonfield, NJ Find on LinkedIn ↗
-
John Lepping · DirectorHaddonfield, NJ Find on LinkedIn ↗
View original on SEC EDGAR.